Alzamend Neuro developed a head coil for high-resolution brain imaging in Phase 2 trials, aiming to optimize lithium dosing ...
Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...
In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...
The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...
Cardiol Therapeutics' CardiolRx shows promise in treating heart conditions. Click here to read more about CRDL stock and why ...
Started by a patient, HealthTree lets blood cancer patients look for clinical trials and treatment options, share their data with researchers.
Although the treatment of myeloma has changed dramatically after the readout of many recent trials, key unanswered questions ...
Newly published detailed clinical trial data show why Exelixis abandoned a plan to seek an FDA approval for a combination of ...
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
Grant funding uncertainty has jeopardized the sustainability of research projects and discouraged researchers.
Bybit introduces a financial disclosure trial, requiring transparency from projects listed on its spot trading platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results